Reproductive Health (Jan 2022)

Factors associated with contraceptive use among women living with HIV in Canada: a controlled, cross-sectional study

  • Chadni C. Khondoker,
  • Angela Kaida,
  • Anna Marquez,
  • Amber R. Campbell,
  • Hélène C. F. Côté,
  • Arianne Y. Albert,
  • Neora Pick,
  • Evelyn J. Maan,
  • Emilie A. B. Russell,
  • Jerilynn C. Prior,
  • Chelsea Elwood,
  • Jason Brophy,
  • Melanie C. M. Murray,
  • for the CIHR team grant on Cellular Aging, H. I. V. Comorbidities in Women, Children (CARMA), (CIHR HIV Clinical Trials Network study 277)

DOI
https://doi.org/10.1186/s12978-021-01312-7
Journal volume & issue
Vol. 19, no. 1
pp. 1 – 9

Abstract

Read online

Plain language summary Background There are many reasons why individuals cannot use combined hormonal contraceptives (CHC). The impact of these reasons on contraceptive choice for women living with HIV (WLWH) are poorly understood. We measured and compared the prevalence of contraceptive choice and factors that may preclude their use in WLWH. Methods We examined survey and medical chart data from 83 WLWH and 62 controls (women not living with HIV), aged 16–49 and sexually active, from 2013 to 2017. We compared the prevalence and types of contraceptives used in the last month and the proportion of women with factors that would not allow the use of CHC, including drug interactions, medical conditions, and smoking at ≥ 35 years old. All WLWH received care at a women-centred HIV clinic. Results Compared to controls, WLWH were older, had less post-secondary education, and more often had household income < $15,000/year. WLWH were more likely to use contraception than controls. Overall hormonal contraceptive use was similar. However, even when accounting for age, WLWH used CHC less than controls, and had more frequently undergone tubal ligation. WLWH also had more reasons that would preclude the use of CHC contraindications including smoking at ≥ 35 years old or a CHC-related drug interaction. Conclusions WLWH attending our interdisciplinary clinic used combined hormonal contraception at similar rates as controls, though with different types. Differences may reflect the fact that WLWH more often have factors that do not allow the safe use of CHC. Guidelines and education for care providers and WLWH regarding contraceptive choices and drug interactions are needed.

Keywords